LACK OF INTERACTION BETWEEN VERAPAMIL AND CIMETIDINE

被引：20

作者：

ABERNETHY, DR

SCHWARTZ, JB

TODD, EL

机构：

来源：

CLINICAL PHARMACOLOGY & THERAPEUTICS | 1985年 / 38卷 / 03期

关键词：

D O I：

10.1038/clpt.1985.183

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

收藏

页码：342 / 349

页数：8

相关论文

共 32 条

[1] ABERNETHY DR, 1983, J PHARMACOL EXP THER, V224, P508
[2] VERAPAMIL AND NORVERAPAMIL DETERMINATION IN HUMAN-PLASMA BY GAS-LIQUID-CHROMATOGRAPHY USING NITROGEN-PHOSPHORUS DETECTION - APPLICATION TO SINGLE-DOSE PHARMACOKINETIC STUDIES
ABERNETHY, DR
TODD, EL
MITCHELL, JR
[J]. PHARMACOLOGY, 1984, 29 (05) : 264 - 268
[3] LIDOCAINE DETERMINATION IN HUMAN-PLASMA WITH APPLICATION TO SINGLE LOW-DOSE PHARMACOKINETIC STUDIES
ABERNETHY, DR
GREENBLATT, DJ
OCHS, HR
[J]. JOURNAL OF CHROMATOGRAPHY, 1982, 232 (01): : 180 - 185
[4] ABERNETHY DR, 1984, J PHARMACOL EXP THER, V229, P702
[5] CIMETIDINE-INDUCED DECREASE IN LIDOCAINE METABOLISM
BAUER, LA
EDWARDS, WAD
RANDOLPH, FP
BLOUIN, RA
[J]. AMERICAN HEART JOURNAL, 1984, 108 (02) : 413 - 415
[6] EICHELBAUM M, 1979, DRUG METAB DISPOS, V7, P145
[7] EFFECTS OF VERAPAMIL ON P-R-INTERVALS IN RELATION TO VERAPAMIL PLASMA-LEVELS FOLLOWING SINGLE IV AND ORAL-ADMINISTRATION AND DURING CHRONIC TREATMENT
EICHELBAUM, M
BIRKEL, P
GRUBE, E
GUTGEMANN, U
SOMOGYI, A
[J]. KLINISCHE WOCHENSCHRIFT, 1980, 58 (18): : 919 - 925
[8] INCREASED TOXICITY AND REDUCED CLEARANCE OF LIDOCAINE BY CIMETIDINE
FEELY, J
WILKINSON, GR
MCALLISTER, CB
WOOD, AJJ
[J]. ANNALS OF INTERNAL MEDICINE, 1982, 96 (05) : 592 - 594
[9] REDUCTION OF LIVER BLOOD-FLOW AND PROPRANOLOL METABOLISM BY CIMETIDINE
FEELY, J
WILKINSON, GR
WOOD, AJJ
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 1981, 304 (12) : 692 - 695
[10] CLINICAL PHARMACOKINETICS OF VERAPAMIL
HAMANN, SR
BLOUIN, RA
MCALLISTER, RG
[J]. CLINICAL PHARMACOKINETICS, 1984, 9 (01) : 26 - 41

← 1 2 3 4 →